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Objectives: To examine the value of endothelial shear stress (ESS) estimated in three-
dimensional quantitative coronary angiography (3D-QCA) models in detecting plaques that 
are likely to progress and cause events. 
Background: Cumulative evidence have shown that plaque characteristics and the ESS 
derived from intravascular ultrasound (IVUS)-based reconstructions enable prediction of 
lesions that will cause cardiovascular events. However, the prognostic value of the ESS 
estimated by 3D-QCA in non-flow limiting lesions is yet unclear.  
Methods: We analysed the baseline virtual histology (VH)-IVUS and angiographic data from 
28 lipid-rich lesions (i.e., fibroatheromas) that caused major adverse cardiovascular events or 
required revascularization (MACE-R) at 5-year follow-up and from a control group of 119 
lipid-rich plaques that remained quiescent. The segments studied by VH-IVUS at baseline 
were reconstructed using 3D-QCA software and in the obtained geometries blood flow 
simulation was performed and we estimated the pressure gradient across the lipid-rich plaque 
and the mean ESS values in 3mm segments. The additive value of these hemodynamic 
indices in predicting MACE-R beyond plaque characteristics was examined.  
Results: MACE-R lesions were longer, had smaller minimum lumen area (MLA), increased 
plaque burden (PB), were exposed to higher ESS, and exhibited a higher pressure gradient. In 
multivariable analysis plaque burden (hazard ratio: 1.08, P=0.004) and the maximum 3mm 
ESS value (hazard ratio: 1.11, P=0.001) were independent predictors of MACE-R. Lesions 
exposed to high ESS (>4.95Pa) with a high-risk anatomy (MLA<4mm2 and PB>70%) had a 
higher MACE-R rate (53.8%) than those with a low-risk anatomy exposed to high ESS 
(31.6%) or those exposed to low ESS that had high (20.0%) or low-risk anatomy (7.1%, 
P<0.001).  
Conclusions: In the present study, 3D-QCA-derived local hemodynamic variables provided 
useful prognostic information and in combination with lesion anatomy enabled more accurate 
identification of MACE-R lesions. 
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Abbreviations: 
3D:   three dimension  
DS:   diameter stenosis 
EEM:   external elastic membrane 
ESS:   endothelial shear stress 
MACE-R:  major adverse cardiovascular events – revascularisation 
MLA:   minimum lumen area 
MLD:   minimum lumen diameter 
QCA:   quantitative coronary angiography 
PB:   plaque burden 
TCFA:  thin cap fibroatheroma  
ThCFA:  thick cap fibroatheroma  








Prospective invasive imaging studies of coronary atherosclerosis have provided robust 
evidence that intravascular imaging can identify, although with only modest accuracy, 
vulnerable plaques that are likely to progress and cause cardiovascular events (1,2). 
Computational fluid dynamic analysis of models reconstructed by intravascular imaging data 
and estimation of the local hemodynamic forces appears to provide additional prognostic 
information, and recent reports have shown that when they are combined with plaque 
characteristics they enable accurate detection of lesions that will progress and cause events 
(3,4). However, intravascular imaging-based reconstruction and blood flow simulation 
processing is a tedious and time consuming process that requires dedicated software and 
expertise, thus limiting its use in everyday clinical practice.  
Conversely, three dimensional quantitative coronary angiography (3D-QCA) can be 
performed in real-time while the patient is on the catheterization laboratory and appears able 
to accurately assess lumen dimensions and the extent and the severity of coronary artery 
disease. Recently, we have processed 3D-QCA models with computational fluid dynamic 
techniques and demonstrated that the estimated endothelial shear stress (ESS) was predictor 
of atherosclerotic disease progression at 1-year follow-up; in addition a post-hoc analysis of 
the FAME (Fractional Flow Reserve versus Angiography for Multivessel Evaluation) II study 
showed that the 3D-QCA-derived ESS estimated in hemodynamically severe stenoses 
predicted those that caused myocardial infarction at 3 years follow-up (5,6). However, the 
combined value of plaque characteristics and of the ESS estimated by 3D-QCA in non-flow 








The present study is a post hoc analysis of data acquired in the PROSPECT (Providing 
Regional Observations to Study Predictors of Events in the Coronary Tree) and IBIS 4 
(Intergraded Biomarkers Imaging Study-4) studies. The design of both studies, the inclusion 
and exclusion criteria and the endpoints and definitions have been described in detail 
elsewhere (2,7). In brief the PROSPECT was a large-scale prospective invasive imaging 
study that aimed to investigate the value of virtual histology intravascular ultrasound (VH-
IVUS) imaging in detecting vulnerable plaques that will progress and cause events. The study 
included 697 patients admitted with an acute coronary syndrome that had successful 
percutaneous coronary intervention in all the culprit lesions and 3-vessel VH-IVUS imaging 
of the proximal 60-80mm segment. IBIS 4 study was a multicentre multimodality imaging 
study that aimed to examine the effect of aggressive statin therapy (rosuvastatin 40mg once 
daily) on plaque burden and composition in patients admitted with ST-elevation myocardial 
infarction. All the recruited patients (n=103) had successful revascularization and 3-vessel 
VH-IVUS and optical coherence tomography imaging of the proximal 50mm segment at 
baseline and 13-month follow-up. The patients recruited in the PROSPECT study were 
followed-up for a median of 3.4 years while those recruited in the IBIS 4 for 5 years.  
Both studies complied with the Declaration of Helsinki and were approved by the ethics 
committees of all the participant centres. 
Clinical endpoints  
The primary endpoint of the PROSPECT study was the composite endpoint of cardiac death 
or arrest, myocardial infarction, or re-hospitalization for unstable or progressive angina. The 
IBIS 4 study had an imaging-based endpoint (i.e., the change in the percent atheroma volume 
at 13 months follow-up); however in that study – which was a sub-study of the 
COMFORTABLE-AMI study – clinical endpoints were also recorded including cardiac 





study revascularisation was deemed clinically indicated at follow-up angiography when there 
was a percent diameter stenosis (%DS) ≥70% on QCA or 70%≥%DS≥50% and recurrent 
angina or evidence of ischaemia at rest or during an exercise test.   
The clinical, angiographic and intravascular imaging data in both studies enabled 
identification of the untreated lesions that were assessed by VH-IVUS at baseline and caused 
events. The present analysis focused on these lesions; the primary endpoint of this study is 
the combined endpoint of cardiac death, myocardial infarction, or revascularisation because 
of progressive or unstable angina, or because of evidence of ischemia and 70%≥%DS≥50% 
on follow-up coronary angiography or because of significant disease progression 
(%DS≥70%) at follow-up angiography (MACE-R). Secondary endpoint of the present 
analysis is the combined endpoint of cardiac death, myocardial infarction, or 
revascularisation because of progressive or unstable angina (MACE). 
Studied lesions and VH-IVUS analysis 
In the PROSPECT study 25 of the untreated lesions at baseline that were studied by VH-
IVUS and caused events had a thin cap fibroatheroma phenotype (TCFA), 18 a thick cap 
fibroatheroma phenotype (ThCFA), 7 a non-fibroatheroma phenotype and 4 were unclassified 
lesions. In the IBIS 4 study all the lesions associated with MACE-R had either a TCFA 
(n=13) or a ThCFA (n=2) phenotype (2,4). The present analysis included only untreated 
lesions with a lipid-rich phenotype, (TCFA or ThCFA) that caused MACE-R during the 
follow-up period and a 4-fold sample of lesions with a lipid-rich phenotype that remained 
quiescent. Lesions with a short length (<9mm), those with suboptimal angiographic images 
(i.e., poor opacification of lumen silhouette, excessive foreshortening or overlapping), and 
cases where the DICOM file did not include all the necessary information for 3D-QCA 





VH-IVUS data analysis was performed by independent core-laboratories (Cardiovascular 
Research Foundation, New York, NY in PROSPECT and Cardialysis B.V., Rotterdam, The 
Netherlands in IBIS 4). Classification of remodeling pattern and lesion phenotype was 
performed in both core-laboratories using the same protocol (Supplementary file). For each 
lesion with a TCFA or ThCFA phenotype its remodeling pattern, its length, the length of the 
proximal shoulder of the lesion, the distance ostium of the studied vessel to minimum lumen 
area (MLA) of the lesion, its MLA, external elastic membrane (EEM), plaque area and the 
plaque burden (PB) at the MLA were estimated and recorded. 
3D-QCA reconstruction, blood flow simulation and data processing 
Anatomical landmarks (i.e., side branches) seen in both IVUS and X-ray angiography were 
used to identify the proximal and distal end of the “segment of interest” (i.e., the segment 
that was assessed by VH-IVUS) on coronary angiography. Two end-diastolic angiographic 
projections (>25o apart), where there was no overlapping or foreshortening of the segment of 
interest and allowed accurate delineation of the lumen silhouette were selected and used to 
reconstruct its anatomy using well-validated software (QAngio XA 3D RE, Medis, Leiden, 
the Netherlands) (8). The distance proximal end of the segment of interest to proximal end of 
each TCFA/ThCFA and distal end of the segment of interest to distal end of each 
TCFA/ThCFA were used to identify lesion location in 3D-QCA models and then for each 
lesion 3D-QCA analysis was performed and the lesion length, minimum lumen diameter 
(MLD) and % DS were estimated.   
The 3D-QCA models were processed with computational fluid dynamic techniques and the 
ESS distribution was estimated (Supplementary file). The location of each TCFA/ThCFA 
lesion was identified in the 3D-QCA models, the lesion was then divided in consecutive 3mm 
segments and for each of these segments the ESS values were extracted across the 





lesion the highest and lowest mean ESS values, estimated in the 3mm segments of the lesion, 
were recorded and defined the “maximum” and “minimum” lesion ESS respectively. 
Statistical analysis 
Numerical variables are presented as median and interquartile range while categorical 
variables as absolute values and percentages. The Mann-Whitney U test was used to compare 
numerical variables between lesions associated with MACE-R or MACE and those that 
remained quiescent, while categorical variables were compared using the chi-square test. Cox 
regression analysis was used to identify VH-IVUS, 3D-QCA and 3D-QCA-derived 
hemodynamic predictors associated with MACE-R or MACE. Receiver-operating 
characteristics curve analysis was performed for each variable associated with MACE-R 
(P<0.05) and these with the highest area under the curve, that were not collinear (r<0.5), were 
entered into a multivariate model.  
Receiver-operating characteristics curve analysis was also used for the computational fluid 
dynamic-derived variables to identify the best cut-off that predicted MACE-R and this was 
used to classify lesions in groups. Kaplan-Meier plots were used to display time to event at a 
lesion and patient level; comparison of the MACE-R rate between groups with different 
plaque characteristics and hemodynamic profile was performed using the log-rank test. 
Lesions or patients with no events were censored at the latest contact date. In case of multiple 
lesions in the same patient, the lesion with the highest maximum ESS value, or the lesion that 
exhibited the highest pressure gradient was used in the patient level analysis. Analyses were 
performed in Stata (version 15.1, StataCorp LP, College Station, TX) and R (version 3.4.2, R 









In the PROSPECT study 54 MACE occurred during a median of 3.4 years follow-up. In the 
IBIS 4 study 15 MACE-R occurred (9 cardiac events and 6 revascularizations) within 5 years 
follow-up. After excluding cases where IVUS analysis or co-registration with coronary 
angiography were not possible, cases where there was insufficient information for 3D-QCA 
reconstruction in the DICOM files, lesions with short length and those with a non-lipid-rich 
phenotype, 28 MACE-R lesions (n=26 patients) were included in the present analysis [16 
from the PROSPECT study and 12 from the IBIS 4 study of which in 6 revascularisation was 
performed during invasive assessment at 13-month follow-up either because of new onset 
angina and a 70%≥%DS≥50%  (n=1) or significant disease progression (DS>70%, n=5) in 
follow-up coronary angiography] (Figure 1).  
The control group consisted of the non-MACE lipid-rich lesions included in the PROSPECT 
ESS sub-study investigating the efficacy of the ESS, estimated in IVUS-based models, in 
predicting events (n=122) (4), and of the non-MACE-R lesions with a lipid-rich phenotype 
(n=74) identified in the patients that were recruited in the IBIS 4 study at Bern University 
Hospital. From these lesions, 16 cases were excluded because of sub-optimal angiographic 
image quality and 61 because of lack of sufficient information in the DICOM file for 3D-
QCA analysis; therefore, the final control group consisted of 119 non-MACE-R lipid-rich 
lesions (53 from the PROSPECT and 66 from the IBIS 4 study; Figure 1).  
In total 92 patients (45 recruited in the PROSPECT and 47 in the IBIS 4 study; 119 vessels) 
were included in the present analysis. As it is shown in Table 1 there were no significant 
differences in the baseline demographics between the patients who experienced MACE-R 
and the control group. The baseline demographics of the patients recruited in the PROSPECT 
and IBS 4 studies are shown in Supplementary Table 1.  





Coronary reconstruction and blood flow simulation was successfully performed in all the 
studied vessels (n=147). The median length of the reconstructed segment was 44.1 (34.3, 
56.2)mm yielding 1882 3mm segments; the median mean ESS was 2.19 (1.46, 3.39)Pa. The 
IVUS MLA coincided with the 3D-QCA MLA in 40% of the studied lesions; in the 
remaining lesions IVUS MLA was located in a different 3mm segment than the 3D-QCA 
MLA. The distribution of the ESS across the studied lesions is shown in the Supplementary 
Figure 1. 
Table 2 shows the morphological, angiographic and hemodynamic characteristics of the 
studied lesions. MACE-R lesions were longer on VH-IVUS, had a smaller MLA and 
increased PB comparing to non-MACE-R lesions. Conversely the 3D-QCA lesion length was 
not different between groups, however the lesions associated with MACE-R had a higher 
%DS and a smaller MLD. The maximum ESS values and the pressure drop across the 
MACE-R lesions were higher comparing to non-MACE-R lesions. There were no differences 
between groups in the incidence of TCFA, the minimum ESS values and the location of 
MACE-R and non-MACE-R lesions in the coronary tree. Similar findings were noted for the 
morphological, angiographic and hemodynamic characteristics of the lesions that caused 
MACE (n=22; Supplementary Table 2).  
Predictors of MACE-R and MACE – lesion level analysis  
Three VH-IVUS-derived variables (lesion length, MLA and PB), two 3D-QCA-derived 
variables (MLD and %DS) and two hemodynamic variables (maximum ESS value, pressure 
drop across the lesion) were predictors of MACE-R lesions (Table 3). By multivariable 
analysis the PB and the maximum ESS were independent predictors of MACE-R lesions. 
Maximum ESS was the only independent predictor of MACE-R when the MLA was entered 





reported when analysis was performed only for lesions with a TCFA phenotype 
(Supplementary Table 3).  
The best maximum ESS cut-off for predicting MACE-R lesions was 4.95Pa while the best 
cut-off for the pressure drop was 2.31mmHg. Lesions were classified in 4 groups according 
to the presence of ≥2 out of the 3 high-risk plaque characteristics that in the PROSPECT 
study were associated with MACE (MLA ≤4mm2, PB ≥70%, TCFA phenotype) and the 
maximum ESS value (above or below 4.95Pa) (9). As shown in the Figure 2 panel A, lesions 
with a high-risk plaque morphology exposed to high ESS had worse prognosis than the 
lesions exposed to high ESS with a low-risk morphology or those exposed to low ESS. The 
results were not different when a high-risk plaque phenotype was defined as the presence of 
MLA ≤4mm2 and PB ≥70% or when the pressure gradient across the lesion (>2.31mmHg) 
was used to define an unfavourable hemodynamic environment (Figure 2B, 2C, 2D).  The 
additive value of the maximum lesion ESS over the established VH-IVUS-derived high-risk 
plaque characteristics in predicting MACE-R is shown in Figure 3 and in the Central 
illustration.  
Similar results were reported when analysis was performed for the MACE lesions: VH-
IVUS-derived MLA and PB, and 3D-QCA-derived MLD, %DS, maximum ESS and the 
pressure gradient were predictors of MACE; in multivariate analysis PB and maximum ESS 
were the only independent predictor of MACE (Table 4). Maximum ESS was the only 
independent predictor of MACE when the MLA was entered into the multivariate model 
(HR: 1.09, 95%CI: 1.02, 1.17; P=0.011). The Kaplan-Meier analysis of the MACE rate 
according to lesion morphological characteristics and maximum ESS or pressure gradient 
across the lesion is shown in Figure 4.   
 





At a patient level MLA, PB, MLD, %DS and the maximum ESS were predictors of MACE-R 
(Supplementary Table 4). Patients that had lipid-rich plaques with ≥2 high-risk plaque 
characteristics that were exposed to high ESS (>4.95Pa) had worse prognosis than those with 
high-risk plaques exposed to low ESS (Figure 5). The pressure gradient across the lesion also 
appeared to provide additional prognostic information to plaque morphology; patients with 
lesions with ≥2 high-risk plaque characteristics that exhibited a pressure gradient 
>2.31mmHg had the worst prognosis compared to the other groups. Similar results were 
reported when high-risk lesions were defined as those with MLA ≤4mm2 and PB ≥70%.  
 
Discussion 
The present study for the first time evaluated the prognostic utility of the 3D-QCA-derived 
hemodynamic indices and plaque characteristics in stratifying non-flow limiting lesions that 
are likely to progress and cause MACE-R or MACE. We found that 1) ESS distribution 
estimated in 3D-QCA models provided additional prognostic information and was an 
independent predictor of MACE-R or MACE, 2) the pressure gradient across non-flow 
limiting lipid-rich lesions was a predictor of MACE-R/MACE, 3) the combination of plaque 
characteristics and 3D-QCA-derived hemodynamic indices (i.e., ESS or the pressure gradient 
across the lesion) enabled more accurate detection of MACE-R and MACE lesions than VH-
IVUS-derived variables, and that 4) plaque morphology and the hemodynamic variables 
estimated in 3D-QCA models allowed more accurate identification of the patients who were 
at risk to suffer a cardiovascular event than standalone VH-IVUS imaging.  
Computational fluid dynamic-based animal and human studies have provided robust evidence 
about the role of the local hemodynamic forces on atherosclerotic disease progression and 
highlighted their prognostic implications (10). Low ESS appears to promote, through 





and in clinical studies it has been reported to be a predictor of lesions that progressed and 
caused events (3,11). Conversely, the role of high ESS on the formation of high-risk plaques 
is less well established; however there is considerable evidence to suggest that high ESS 
contributes to the destabilization of vulnerable lesions (12,13). Despite the undoubted 
prognostic implications of ESS, blood flow simulation analyses have limited applications in 
the clinical arena. This should be at least partially attributed to the increased time required for 
coronary reconstruction and blood flow modelling.  
In the present study we examined the prognostic value of 3D-QCA-derived hemodynamic 
variables in detecting non-flow limiting lipid-rich plaques that are likely to progress and 
cause MACE-R. In contrast to what has been reported in previous studies we found that the 
maximum and not the minimum ESS predicted MACE-R and MACE (3,4). This discrepancy 
may be attributed to the different modality used to extract vessel geometry; 3D-QCA 
modelling has limited efficacy in assessing details in lumen morphology, which can affect 
ESS estimations especially in complex long lesions that are likely to exhibit ESS 
heterogeneity (14). Indeed, in the present study in which the median lesion length was 
22.7mm, the IVUS and 3D-QCA MLA co-located in only 40% of lesions, a finding which 
highlights the limited accuracy of 3D-QCA to accurately extract lumen architecture 
(Supplementary Figure 2). Taking into account the limitations of 3D-QCA and the fact that it 
generates smooth luminal surfaces, in the present study we used the mean rather the more 
commonly used minimum predominant ESS value to define the physiologic profile of the 
3mm segments (3,4).     
Despite the limitations of 3D-QCA-modelling, the estimated hemodynamic indices, and in 
particular the ESS distribution provided useful prognostic information and improved the 
efficacy of established VH-IVUS-derived plaque characteristics in predicting events (Figure 





R/MACE in multivariable analysis, and the Kaplan-Meier plots demonstrated the synergetic 
effect of plaque morphology and ESS in predicting future MACE or angiographically 
indicated revascularizations. Two recent studies, the EMERALD (Exploring the MEchanism 
of plaque Rupture in Acute coronary syndrome using coronary CT Angiography and 
computationaL fluid Dynamics) and a post hoc analysis from the FAME II reported similar 
findings to our analysis, demonstrating that the maximum ESS estimated in lesions 
reconstructed by CTCA or 3D-QCA were predictors of future myocardial infarctions (6,15). 
These studies however, included predominately flow limiting lesions (49% and 100% of the 
lesions included in the EMERALD and FAME II studies respectively had fractional flow 
reserve ≤0.80) that should have been considered for revascularization. Conversely, our 
analysis focused on non-flow limiting stenoses, with a median pressure gradient across these 
lesions of only 1.95 (1.14, 3.33)mmHg, for which there is lack of evidence to support their 
invasive passivation. In addition, the EMERALD study included predominately patients 
without a previous history of coronary artery disease who are less likely to have complex 
lesions, while in the FAME II study there was no information about plaque composition and 
therefore this analysis was unable to examine the additive predictive value of hemodynamic 
indices over anatomical and morphological plaque characteristics derived by intravascular 
imaging. Finally, coronary reconstruction and blood flow simulation in both studies was 
computationally demanding as the EMERALD used computed tomographic coronary 
angiography derived models while the FAME II study incorporated the side branches in the 
3D-QCA models which increases considerably the computation time. Conversely our 
analysis included only the main branch and assumed steady coronary flow; this approach 






The unfavourable implications of high ESS on plaque pathobiology is supported by several 
experimental studies which have shed light into the mechanotransduction pathways that 
regulate plaque evolution. High ESS promotes nitric oxide synthesis and proteolytic 
degradation of the fibrous cap by inhibiting extracellular matrix synthesis, and increases 
smooth muscle cell apoptosis and proteolytic matrix degradation (10). The above processes 
eventually result in fibrous cap fragility and rupture which can cause vessel thrombosis or 
plaque healing with accelerated disease progression (16). These events can have clinical 
manifestations if they occur in segments with increased PB and small MLA as in this setting 
they are likely to cause flow obstruction and ischemia (17). Indeed, in our study apart from 
the ESS increased PB and small MLA were also predictors of MACE-R while PB was an 
independent predictor of MACE-R in multivariate Cox regression analysis as well. 
Interestingly, apart from the ESS, the pressure gradient across the lesion estimated in our 3D-
QCA models also provided useful prognostic information and was a predictor of MACE-R 
and MACE. Kaplan-Meier analysis showed that lesions with a high pressure gradient (and 
especially these with high-risk plaque characteristic) had a poor prognosis with event rates as 
high as 51.8% at 5-year follow-up. Several studies have demonstrated that a low fractional 
flow reserve is a predictor of worse outcomes even in angiographically non-flow limiting 
stenoses (15). In these studies, the prognostic value of fractional flow reserve has been 
attributed to the fact that it reflects atherosclerotic burden. In our analysis however, and in the 
EMERALD study, the pressure gradient seemed to provide additional prognostic information 
beyond plaque characteristics. An increased pressure gradient across a lesion has been 
associated with increased axial tensile stress, flow disturbances and ESS heterogeneity; this 
unfavourable hemodynamic environment can accelerate atherosclerotic evolution leading to 





The findings of the present analysis provide evidence of the value of 3D-QCA-derived 
hemodynamic indices in identifying vulnerable plaques (Supplementary Figure 3). Software 
have been developed that enable real-time computation of the fractional flow reserve from 
3D-QCA, which may be used in future studies to enhance the efficacy of intravascular 
imaging in detecting plaques prone to progress and cause events (20).  
Moreover, the present analysis also underscores the potential value of plaque morphology 
and physiology (i.e., ESS distribution or pressure drop across a lesion) in stratifying 
cardiovascular risk. The models that are currently available to identify high-risk patients rely 
either on patient demographics or on the combination of clinical and imaging biomarkers and 
have modest predictive accuracy (21). The patient-level analysis of our study showed that the 
subjects with high-risk plaques and an unfavourable local hemodynamic environment had a 
high event rate during follow-up. Further research is needed to examine the potential value of 
non-invasive or invasive assessment of plaque pathology (i.e., plaque burden and 
composition) and physiology in identifying patients at risk who would benefit from emerging 
therapies targeting atherosclerosis.  
 
Limitations 
A significant limitation of the present analysis is the fact that only 48% of the lipid-rich 
lesions that caused MACE-R were suitable for inclusion; this may have introduced selection 
bias and resulted in a small sample size and events that did not allow us to accurately 
quantify the additive value of hemodynamic variables over VH-IVUS-derived plaque 
characteristics in predicting MACE-R. Therefore, the reported results should be interpreted 
with caution and require further confirmation in future large scale studies.  
In addition, in some of the angiograms from the PROSPECT study the pixel size was not 





accuracy of 3D-QCA modelling. Additionally, we performed steady flow simulation, 
assuming that the blood was a Newtonian fluid and we did not include side branches in the 
3D-QCA models. Steady flow simulation can accurately predict time averaged ESS in 
pulsatile simulations (22). Conversely a Newtonian assumption may not accurately 
approximate blood behaviour, especially in diseased segments where more regions of slow 
flow are expected (23). In addition, the incorporation of the side branches in the 3D models is 
expected to enable more accurate assessment of the ESS distribution; however a recent study 
has shown that the incorporation of the side branches on the 3D vessel geometry only 
marginally improved the accuracy of the ESS in predicting plaque evolution (24). Complex 
simulation especially in complex geometries is time consuming and cannot be performed in 
the catheterisation laboratory. With the proposed approach ESS and especially the pressure 
drop across a lesion can be computed fast in single vessel geometries; currently QCA 
reconstruction and blood flow simulation takes ~15min, however developments in software 
design and advances in computer technology are expected to reduce this time to few minutes 
enabling the real-time computation of 3D-QCA-derived ESS. 
Furthermore, VH-IVUS imaging was performed using two different imaging systems 
(Invision Gold in PROSPECT and s5 in IBIS 4); VH analysis from these two systems may 
provide different estimations for plaque composition and phenotype. In addition, follow-up 
coronary angiography and revascularisation because of disease progression on angiogram 
was performed only in the IBIS 4 study, while the follow-up period (median 3.4 years in the 
PROSPECT and 5 years in the IBIS 4) was different in the two studies. However, it is 
reassuring that our findings were similar when analysis was restricted to MACE or to the first 
3.4 years of follow-up (Supplementary Figure 4). 
Finally, the number of the events reported in this analysis was relatively small and most of 





myocardial infarction). However, it has to be acknowledged that in all the prospective multi-
vessel intravascular imaging studies of coronary atherosclerosis the incidence of hard 
endpoints is low (1-3). In addition, the clinical endpoints of this study are similar to the 
endpoints of the recently completed Lipid Rich Plaque study and of ongoing studies of 
coronary atherosclerosis (PROSPECT II, NCT02171065; PREVENT, NCT02316886; 
COMBINE OCT-FFR, NCT02989740) that are expected to provide additional data and the 
substrate to prove the concept introduced in this report. 
  
Conclusions 
In the present analysis of the PROSPECT and IBIS 4 studies, hemodynamic indices estimated 
from 3D-QCA models provided additional prognostic information to VH-IVUS-derived 
variables and enabled more accurate detection of non-flow limiting lesions that are likely to 
progress and cause events. Prospective studies are needed to confirm these findings and 
examine the efficacy of intravascular imaging and 3D-QCA-derived variables in detecting 
high-risk lesions and patients who may benefit from pre-emptive focal or systemic treatment 
of atherosclerosis.   
 
Perspectives  
Competency in medical knowledge: In this post-hoc analysis of the PROSPECT and IBIS 4 
imaging studies the ESS estimated in 3D-QCA-derived models improved the predictive 
efficacy of VH-IVUS in identifying lesions prone to exhibit disease progression and cause 
MACE-R at 5 year follow-up.  
Translational outlook: Future developments in software design are expected to enable fast 





scale studies that will assess the potential value of 3D-QCA-derived ESS in predicting lesions 
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Figure 1. Study design. Flowchart of the lesions included in the present analysis.  
 
Figure 2. Kaplan-Meier curves showing MACE-R rate according to plaque and 3D-
QCA-derived haemodynamic indices. Lesions were classified in groups according to the 
presence of absence of (A) ≥2 high-risk plaque features and increased maximum ESS values 
(>4.95Pa), (B) ≥2 high-risk plaque features and high pressure gradient (>2.31mmHg) across 
the lesion, (C) PB ≥70%, MLA ≤4mm2 and increased maximum ESS and (D) PB ≥70%, 
MLA ≤4mm2 and high pressure gradient. 
 
Figure 3. MACE-R rate of lesions with and without VH-IVUS-derived high-risk plaque 
characteristics that were or were not exposed to high maximum ESS values.  ESS (+) indicates 
lesions exposed to high maximum ESS (>4.95Pa); TCFA (+) indicates the presence of a TCFA 
phenotype; MLA (+) a MLA ≤4.0mm2 and PB (+) a PB ≥70%. 
 
Central illustration. MACE-R rate of lesions with and without VH-IVUS-defined high-
risk plaque characteristics exposed to high or low maximum ESS. TCFA (+) indicates the 
lesions with a TCFA phenotype, MLA (+) the lesions with MLA ≤4.0mm2, PB (+) the lesions 
with PB ≥70% and ESS (+) the lesions exposed to high maximum ESS (>4.95Pa). 
 
Figure 4. Kaplan-Meier curves showing MACE rate according to plaque and 3D-QCA-
derived haemodynamic indices. Lesions were classified in groups according to the presence 
of absence of (A) ≥2 high-risk plaque features and increased maximum ESS values 
(>4.95Pa), (B) ≥2 high-risk plaque features and high pressure gradient (>2.31mmHg) across 
the lesion, (C) PB ≥70% and MLA ≤4mm2 and increased maximum ESS values and (D) PB 
≥70% and MLA ≤4mm2 and high pressure gradient. 
 
Figure 5. Kaplan-Meier curves showing patient level MACE-R rate according to plaque 
and 3D-QCA-derived haemodynamic indices. (A) Patients were classified in groups 
according to the presence of absence of (A) high-risk plaques (i.e., plaques with ≥2 high-risk 
features) and increased maximum ESS values (>4.95Pa), (B) high-risk plaques and high 
pressure gradient (>2.31mmHg) across the lesion, (C) PB ≥70% and MLA ≤4mm2 and 

































Table 1. Baseline demographics of the patients who experienced MACE-R and of the control group.  
 Studied patients 
(N=92) 





Age (years) 58.2 (51.5, 64.8) 60.5 (53.5, 67.0) 57.4 (50.9, 64.3) 0.422 
Gender (male) 81 (88%) 24 (92%) 57 (86%) 0.429 
BMI 27.1 (24.4, 30.1) 27.5 (24.6, 31.0) 27.0 (24.2, 29.9) 0.643 
Current smoker 47 (47%) 14 (54%) 27 (41%) 0.261 
Co-morbidities     
Diabetes mellitus  15 (17%) 7 (27%) 9 (14%) 0.130 
Hypertension  42 (46%) 11 (44%) 31 (47%) 0.800 
Hypercholesterolemia  36 (40%) 10 (44%) 26 (39%) 0.731 
Renal failure* 3 (3%) 1 (4%) 2 (3%) 0.764 
Previous PCI 6 (7%) 3 (11%) 3 (4%) 0.221 
Family history of CAD 30 (33%) 9 (39%) 21 (33%) 0.585 
Clinical presentation     0.961 
STEMI 58 (63%) 16 (61%) 42 (64%)  
NSTEMI 30 (33%) 9 (35%) 21 (32%)  
Unstable angina 4 (4%) 1 (4%) 3 (4%)  
Medications at discharge     
Aspirin 91 (99%) 26 (100%) 65 (98%) 0.528 
Thienopyridines 92 (100%) 100 (100%) 45 (100%) - 
Beta-blocker 87 (95%) 23 (89%) 64 (97%) 0.105 
RAAS inhibitor 76 (83%) 20 (77%) 56 (85%) 0.367 
Statin 88 (96%) 25 (96%) 63 (95%) 0.882 
Table footnote: BMI, body mass index; CAD, coronary artery disease; NSTEMI, non ST-elevation 
myocardial infarction; PCI, percutaneous coronary intervention;  RAAS, renin angiotensin aldosterone 
system; STEMI, ST-elevation myocardial infarction.  
*Renal failure was defined as estimated glomerular filtration rate <60mL/min/1.73m2 
 
Table 2. Morphological and hemodynamic characteristics of the MACE-R lesions and of these that 
remained quiescent during follow-up.  
 Studied lesions  
(N=147) 





VH-IVUS plaque characteristics     
VH-IVUS lesion length (mm) 22.7 (12.9, 35.2) 32.5 (18.0, 41.6) 19.6 (12.7, 31.3) 0.030 
Distance vessel ostium to MLA (mm) 24.2 (10.2, 35.9) 29.8 (15.1, 44.6) 23.8 (9.2, 34.3) 0.088 
Length of the proximal shoulder (mm) 11.3 (6.6, 23.1) 12.5 (6.5, 18.2) 10.6 (6.6, 23.3) 0.892 
MLA (mm2) 4.81 (3.68, 6.30) 3.65 (3.26, 4.36) 5.03 (3.98, 6.66) <0.001 
EEM area (mm2) 13.39 (10.53, 16.11) 11.60 (10.64, 14.66) 13.56 (10.41, 16.53) 0.242 
Plaque area (mm2) 7.93 (6.56, 10.62) 8.19 (7.08, 10.55) 7.87 (6.21, 10.72) 0.596 
PB (%) 62.5 (55.0, 68.8) 69.4 (63.5, 72.0) 60.8 (53.7, 66.5) <0.001 
TCFA phenotype 97 (66%) 19 (67.9%) 78 (65.5%) 0.816 
Remodeling pattern    0.309 
Constrictive remodeling  81 (55.1%) 17 (60.7%)  64 (53.8%)  
Compensatory remodeling 61 (41.5%) 9 (32.1%) 52 (43.7%)  
Excessive expansive remodeling 5 (3.4%) 2 (7.1%) 3 (2.5%)  
3D-QCA and CFD-derived variables     
3D-QCA lesion length (mm) 17.4 (13.0, 25.2) 18.3 (14.3, 25.1) 17.4 (12.4, 25.4) 0.604 
MLD (mm) 2.10 (1.78, 2.52) 1.87 (1.52, 2.05) 2.23 (1.84, 2.56) <0.001 
Percentage DS (%) 25.9 (20.4, 34.0) 36.5 (24.4, 44.6) 24.9 (19.8, 30.9) 0.001 
Coronary blood flow (ml/s) 0.84 (0.63, 1.17) 0.73 (0.56, 1.12) 0.88 (0.66, 1.17) 0.118 
Maximum ESS value (Pa)  5.06 (3.23, 8.91) 9.40 (6.30, 12.52) 4.13 (2.99, 6.96) <0.001 
Minimum ESS value (Pa)  1.21 (0.81, 1.80) 1.17 (0.78, 0.180) 1.33 (1.03, 1.78) 0.296 
Pressure drop across the lesion (mmHg) 1.95 (1.14, 3.33) 3.31 (2.28, 5.17) 1.68 (0.97, 2.67) <0.001 
Lesion location     
Coronary artery    0.212 
Left anterior descending coronary artery 58 (39.5%) 13 (46.4%) 45 (37.8%)  
Left circumflex coronary artery  44 (29.9%) 11 (39.3%) 33 (27.7%)  
Right coronary artery 44 (99.9%) 4 (14.3%) 40 (33.6%)  
Intermediate coronary artery  1 (0.7%) 0 (0%) 1 (0.8%)   
Coronary segment    0.679 
Proximal vessel 100 (68%) 19 (68%) 81 (68%)  
Mid vessel 27 (18%) 4 (14%) 23 (19%)  
Distal vessel 20 (14%) 5 (18%) 15 (13%)  
Table footnote: CFD, computational fluid dynamics.  
 
Table 3. Lesion level univariable and multivariable analyses of the morphological, angiographic and 
hemodynamic predictors of MACE-R.  
 Univariable analysis Multivariable analysis* 
 Hazard ratio P Hazard ratio P 
Lesion length (per 1mm increase) 1.03 (1.00, 1.05) 0.030 1.00 (0.98, 1.03) 0.770 
MLA (per 1mm2 increase) 0.53 (0.38, 0.74) <0.001 - - 
PB (per 1% increase) 1.10 (1.05, 1.16) <0.001 1.08 (1.03, 1.14) 0.004 
MLD (per 1mm increase) 0.19 (0.08, 0.44) <0.001 - - 
Percentage DS (per 1% increase) 1.06 (1.03, 1.10) 0.001 - - 
Maximum ESS value (per 1Pa increase) 1.14 (1.08, 1.20) <0.001 1.11 (1.05, 1.17) 0.001 
Pressure drop across a lesion (per 1mmHg increase) 1.10 (1.03, 1.18) 0.005 - - 
* Significant correlation (r>0.5) was noted between the maximum ESS and the MLA (r=-0.612, 
P<0.001), the MLD (r=-0.586, P<0.001), the %DS (r=0.518, P<0.001) and the pressure drop across the 
lesion (r=-0.735, P<0.001). Maximum ESS was entered in the multivariate model as this variable had 
the highest area under the curve (AUC) in the receiver-operating characteristics analysis (AUCmaxESS = 
0.790, P<0.001; AUCMLA = 0.743, P<0.001; AUCMLD = 0.723, P<0.001; AUCDS = 0.711, P=0.001; 
AUCpres drop = 0.754, P<0.001). 
 
Table 4. Lesion level univariable and multivariable analyses of the morphological, angiographic and 
hemodynamic predictors of MACE.  
 Univariable analysis Multivariable analysis 
 Hazard ratio P Hazard ratio P 
MLA (per 1mm2 increase) 0.47 (0.31, 0.72) <0.001 - - 
PB (per 1% increase) 1.11 (1.05, 1.17) <0.001 1.09 (1.03, 1.16) 0.003 
MLD (per 1mm increase) 0.20 (0.08, 0.51) 0.001 - - 
Percentage DS (per 1% increase) 1.05 (1.01, 1.09) 0.008 - - 
Maximum 3mm ESS value (per 1Pa increase) 1.15 (1.09, 1.22) <0.001 1.12 (1.05, 1.19) <0.001 
Pressure drop across a lesion (per 1mmHg increase) 1.11 (1.03, 1.19) 0.004 - - 
* Significant correlation (r>0.5) was noted between the maximum ESS and the MLA, the MLD, the 
%DS and the pressure drop across the lesion. Maximum ESS was entered in the multivariate model as 
this variable had the highest area under the curve (AUC) in the receiver-operating characteristics 
analysis (AUCmaxESS = 0.797, P<0.001; AUCMLA = 0.787, P<0.001; AUCMLD = 0.737, P<0.001; AUCDS 
= 0.688, P=0.005; AUCpres drop = 0.779, P<0.001). 
 
